Literature DB >> 18662553

State of the art in nuclear medicine dose assessment.

Michael G Stabin1, A Bertrand Brill.   

Abstract

Basic calculational methods and models used in dose assessment for internal emitters in nuclear medicine are discussed in this overview. Methods for quantification of activity in clinical and preclinical studies also are discussed, and we show how to implement them in currently available dose calculational models. Current practice of the use of internal emitters in therapy also is briefly presented here. Some of the future challenges for dose assessment in nuclear medicine are discussed, including application of patient-specific dose calculational methods and the need for significant advances in radiation biology.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18662553     DOI: 10.1053/j.semnuclmed.2008.05.005

Source DB:  PubMed          Journal:  Semin Nucl Med        ISSN: 0001-2998            Impact factor:   4.446


  10 in total

1.  Feasibility of 90Y TOF PET-based dosimetry in liver metastasis therapy using SIR-Spheres.

Authors:  Renaud Lhommel; Larry van Elmbt; Pierre Goffette; Marc Van den Eynde; François Jamar; Stanislas Pauwels; Stephan Walrand
Journal:  Eur J Nucl Med Mol Imaging       Date:  2010-04-27       Impact factor: 9.236

2.  EANM procedure guidelines for therapy of benign thyroid disease.

Authors:  Marcel P M Stokkel; Daria Handkiewicz Junak; Michael Lassmann; Markus Dietlein; Markus Luster
Journal:  Eur J Nucl Med Mol Imaging       Date:  2010-07-13       Impact factor: 9.236

Review 3.  Matched pairs dosimetry: 124I/131I metaiodobenzylguanidine and 124I/131I and 86Y/90Y antibodies.

Authors:  Egesta Lopci; Arturo Chiti; Maria Rita Castellani; Giovanna Pepe; Lidija Antunovic; Stefano Fanti; Emilio Bombardieri
Journal:  Eur J Nucl Med Mol Imaging       Date:  2011-04-12       Impact factor: 9.236

4.  Cytogenetic biodosimetry and dose-rate effect after radioiodine therapy for thyroid cancer.

Authors:  Igor K Khvostunov; Vladimir A Saenko; Valeri Krylov; Andrei Rodichev; Shunichi Yamashita
Journal:  Radiat Environ Biophys       Date:  2017-05-19       Impact factor: 1.925

5.  Experimental facts supporting a red marrow uptake due to radiometal transchelation in 90Y-DOTATOC therapy and relationship to the decrease of platelet counts.

Authors:  Stephan Walrand; Raffaella Barone; Stanislas Pauwels; François Jamar
Journal:  Eur J Nucl Med Mol Imaging       Date:  2011-02-12       Impact factor: 9.236

6.  Dosimetry for 131I-MIBG therapies in metastatic neuroblastoma, phaeochromocytoma and paraganglioma.

Authors:  Ferdinand Sudbrock; Matthias Schmidt; Thorsten Simon; Wolfgang Eschner; Frank Berthold; Harald Schicha
Journal:  Eur J Nucl Med Mol Imaging       Date:  2010-02-24       Impact factor: 9.236

Review 7.  Preclinical Voxel-Based Dosimetry in Theranostics: a Review.

Authors:  Arun Gupta; Min Sun Lee; Joong Hyun Kim; Dong Soo Lee; Jae Sung Lee
Journal:  Nucl Med Mol Imaging       Date:  2020-04-19

8.  Comparison of the Absorbed Dose for (99m)Tc-Diethylenetriaminepentaacetic Acid and (99m)Tc-Ethylenedicysteine Radiopharmaceuticals using Medical Internal Radiation Dosimetry.

Authors:  Shokufeh Pirdamooie; Ahmad Shanei; Masoud Moslehi
Journal:  J Med Signals Sens       Date:  2015 Jul-Sep

Review 9.  Quantitative Imaging for Targeted Radionuclide Therapy Dosimetry - Technical Review.

Authors:  Tiantian Li; Edwin C I Ao; Bieke Lambert; Boudewijn Brans; Stefaan Vandenberghe; Greta S P Mok
Journal:  Theranostics       Date:  2017-10-13       Impact factor: 11.556

10.  Patient-specific image-based bone marrow dosimetry in Lu-177-[DOTA0,Tyr3]-Octreotate and Lu-177-DKFZ-PSMA-617 therapy: investigation of a new hybrid image approach.

Authors:  Astrid Gosewisch; Andreas Delker; Sebastian Tattenberg; Harun Ilhan; Andrei Todica; Julia Brosch; Lena Vomacka; Anika Brunegraf; Franz Josef Gildehaus; Sibylle Ziegler; Peter Bartenstein; Guido Böning
Journal:  EJNMMI Res       Date:  2018-08-03       Impact factor: 3.138

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.